Darin J. Weber - Apr 18, 2024 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role
SVP of Regulatory Development
Signature
/s/ Todd Girolamo, attorney in fact
Stock symbol
PROK
Transactions as of
Apr 18, 2024
Transactions value $
-$43,343
Form type
4
Date filed
4/23/2024, 04:05 PM
Previous filing
Apr 17, 2024
Next filing
May 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PROK Class A Ordinary Shares Sale -$2.03K -800 -0.46% $2.54 172K Apr 18, 2024 Direct F1, F2
transaction PROK Class A Ordinary Shares Sale -$41.3K -16.4K -9.58% $2.51 155K Apr 22, 2024 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.55, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.53, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.